Funder: National Institutes of Health
Due Dates: November 10, 2026 (Application, 5:00 p.m. applicant organization’s local time)
Funding Amounts: Up to $1,000,000 total costs per Hub annually for up to 4 years; $5,000,000 estimated program funding
Summary: Supports academic entrepreneurship Hubs that advance biomedical discoveries toward commercial products through proof-of-concept funding, expertise, and training.
Key Information: Primary applicants must have been formal research-institution partners to a small business on an NIH STTR award.
Description
The NIH Research Evaluation and Commercialization Hubs (REACH) program supports academic entrepreneurship Hubs that translate biomedical discoveries into products improving patient care and public health. Administered by the National Institute of General Medical Sciences (NIGMS) on behalf of NIH, the program combines early investment, product-development expertise, commercialization mentorship, and hands-on entrepreneurial education.
Hubs work as a consortium to identify promising technologies and support feasibility studies, validation, prototypes, and proof-of-concept work. Technologies should have moved beyond discovery toward a potential commercial product and eventual SBIR/STTR competitiveness. Supported areas include therapeutics, preventatives, diagnostics, devices, research tools, and health IT. NIH encourages ecosystems addressing high U.S. disease and disability burdens and areas attracting less private biomedical investment.
